Trilantic North America completed the acquisition of a minority stake in Rarebreed Veterinary Partners.

Trilantic North America, a private equity firm, completed the acquisition of a minority stake in Rarebreed Veterinary Partners, a technology-enabled veterinary services platform. Financial terms were not disclosed. “We were drawn to the opportunity to invest in Rarebreed for a number of reasons, including their flexible, partnership-oriented approach to M&A, and the team’s thoughtful investments in building a platform that leverages technology and systems to deliver value that will continue to scale,” Jamie Manges, Trilantic North America Partner.